Physician profile
Michael E Fox
NPI 1053389254
$1,896.68
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $845 · 2021: $131 · 2022: $23.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $419.75 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $230.54 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.13 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $132.09 | 2019-2020 | |
| Allergan, INC. | $90.68 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $89.97 | 2020 | |
| Insmed, INC. | $89.83 | 2019-2021 | |
| Lilly USA, LLC | $75.04 | 2020-2021 | |
| Pfizer INC. | $67.78 | 2019 | |
| Abbvie INC. | $64.14 | 2020 | |
| Genentech USA, INC. | $59.88 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $56.23 | 2019-2021 | |
| Grifols USA, LLC | $37.53 | 2020 | |
| Merck Sharp & Dohme LLC | $37.29 | 2019-2020 | |
| Mylan Specialty L.P. | $32.81 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $31.35 | 2020 | |
| Philips North America LLC | $24.64 | 2020 | |
| Tactile Systems Technology INC | $23.69 | 2019-2020 | |
| Medtronic, INC. | $23.65 | 2022 | |
| Novo Nordisk INC | $19.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.43 | 2021 | |
| Vertiflex, INC. | $14.00 | 2019 | |
| Sanofi Pasteur INC. | $13.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.30 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.